DexCom (DXCM) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
DexCom (DXCM) PT Raised to $130 at Morgan Stanley
August 3, 2018 7:46 AM EDTMorgan Stanley raised its price target on DexCom (NASDAQ: DXCM) to $130.00 (from $70.00) while maintaining a Equalweight rating.
... MoreDexCom (DXCM) PT Raised to $125 at Oppenheimer
August 2, 2018 9:29 AM EDTOppenheimer raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $85.00) while maintaining an Outperform rating.
Analyst Steven Lichtman commented, "DexCom's 2Q18 sales of $243M (+41% cc) delivered a strong beat versus our/consensus $202/$206M forecasts, led by robust outperformance in both US and... More
DexCom (DXCM) PT Raised to $120 at Cowen Following 'Monster' Qtr
August 2, 2018 7:59 AM EDTCowen raised its price target on DexCom (NASDAQ: DXCM) to $120.00 (from $110.00) while maintaining a Outperform rating following its "huge" beat and raise.
Analyst Doug Schenkel commented, "DXCM posted a huge beat and raise. Deals with payers to expand access / simplify distribution could temper... More



